Nat Clin Pract Neurol. 2007;3(1):24-35. Another important mechanism of pathogenesis in systemic lymphoma is chronic antigenic stimulation. Relatively strong evidence for this mechanism exists for ...

Primary non-Hodgkin's lymphoma of the breast (PBNHL) is uncommon. There have been only a few reports of breast lymphoma in the radiology literature. In this case report, we describe mammographic ...

Citius Oncology has completed commercial-scale manufacturing of LYMPHIR, with packaged and labeled inventory now held at a leading global Contract Development and Manufacturing Organization (CDMO).

It is also called adoptive cell transfer. It's a possible treatment for some children and adults with leukaemia. It is also a treatment for some adults with lymphoma. Surgery isn’t a common treatment ...

New York’s primaries are closed primaries. To vote in a political party’s primary election, you need to be registered as a member of that party. For example, if you want to vote in the ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated diffuse large B-cell lymphoma ... whose primary endpoint will be progression ...

At the second attempt, the FDA has approved Citius Pharmaceuticals' marketing application for Lymphir, a new version of a lymphoma therapy withdrawn from sale several years ago. The US regulator ...